≥45 years; all participants | ≥45 years; those with underlying disease | ≥45 years; those without underlying disease | ||||||||||
The mean follow-up period (year) | 9.94 | 9.11 | 10.9 | |||||||||
The mean follow-up period until death | 9.91 | 9.46 | 10.9 | |||||||||
All participants/ death (N) | 33,708/10,104 | 18,006/6942 | 15,702/3162 | |||||||||
n | No. of deaths | HR | 95% CI | n | No. of deaths | HR | 95% CI | n | No. of deaths | HR | 95% CI | |
BMI category | ||||||||||||
-18.5 | 504 | 279 | 1.72 | (1.51 - 1.95)* | 270 | 182 | 1.84 | (1.57 - 2.15)* | 234 | 97 | 1.71 | (1.37 - 2.11)* |
18.5 - 22.5 | 4759 | 1738 | 1.17 | (1.1 - 1.25)* | 1940 | 1044 | 1.20 | (1.10 - 1.30)* | 2819 | 694 | 1.23 | (1.11 - 1.37)* |
22.5 - 25 | 6355 | 2126 | 1.00 | (ref) | 2938 | 1397 | 1.00 | (ref) | 3417 | 729 | 1.00 | (ref) |
25 - 30 | 13,262 | 3937 | 0.96 | (0.91 - 1.01) | 6986 | 2733 | 0.90 | (0.85 - 0.96)* | 6276 | 1204 | 0.95 | (0.87 - 1.05) |
30 - 35 | 5812 | 1382 | 1.00 | (0.94 - 1.08) | 3657 | 1053 | 0.88 | (0.81 - 0.95)* | 2155 | 329 | 1.00 | (0.87 - 1.13) |
35- | 3016 | 642 | 1.45 | (1.32 - 1.58)* | 2215 | 533 | 1.20 | (1.08 - 1.33)* | 801 | 109 | 1.30 | (1.05 - 1.58)* |